Date: 16 June 2020
The panel examined key issues related to patents, know-how and regulatory data for diagnostics, vaccines and treatments in the global Covid-19 response, focusing on access, securing the supply chain, compulsory licensing, crown use and the public interest.
Uma Suthersanen, Professor of Global Intellectual Property Law and Deputy Director of the Queen Mary Intellectual Property Research Institute